Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 12/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13096315 | 0.94 | MAPK1 (0.61) | MAPK1ABCB1SMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL15672147 | 0.94 | MAPK1 (0.61) | MAPK1ABCB1SMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL14064868 | 0.87 | LMNA (0.67) | CYP2D6CYP2C9CYP2C19LMNAHTT | |
| SCHEMBL15872188 | 0.86 | MAPK1 (0.61) | MAPK1ABCB1SMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL18543110 | 0.85 | ABCB1 (0.71) | MAPK1ABCB1SMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL19669063 | 0.84 | PKM (0.59) | ALDH1A1CYP2D6CYP2C9CYP2C19LMNA | |
| SCHEMBL14625832 | 0.82 | ABCB1 (0.64) | MAPK1ABCB1SMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL2384639 | 0.81 | ABCB1 (0.66) | MAPK1ABCB1SMN1; SMN2ALDH1A1CYP2D6 | |
| SCHEMBL11686021 | 0.80 | LMNA (0.58) | ALDH1A1CYP2D6CYP2C9CYP2C19LMNA | |
| SCHEMBL11680313 | 0.80 | LMNA (0.58) | ALDH1A1CYP2D6CYP2C9CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140199468-A1 | NANOFIBERS CONTAINING LATENT REACTIVE GROUPS | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2014-07-17 | — | — | US | claimed |
| US-8709809-B2 | Nanofibers containing latent reactive groups | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2014-04-29 | — | — | US | claimed |
| CN-110997746-B | Photocrosslinked polymers for enhanced durability | 心脏起搏器股份公司 | 2021-12-28 | — | — | CN | disclosed |
| EP-3668912-B1 | PHOTOCROSSLINKED POLYMERS FOR ENHANCED DURABILITY | CARDIAC PACEMAKERS INC (US) | 2021-06-30 | — | — | EP | disclosed |
| US-10835638-B2 | Photocrosslinked polymers for enhanced durability | CARDIAC PACEMAKERS, INC. (US) | 2020-11-17 | — | — | US | disclosed |
| CN-110997746-A | Photocrosslinked polymers for enhanced durability | 心脏起搏器股份公司 | 2020-04-10 | — | — | CN | disclosed |
| US-20190054204-A1 | PHOTOCROSSLINKED POLYMERS FOR ENHANCED DURABILITY | CARDIAC PACEMAKERS, INC. | 2019-02-21 | — | — | US | disclosed |
| US-9833543-B2 | Implantable scaffolds and methods of use | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2017-12-05 | — | — | US | disclosed |
| US-9833543-B2 | Implantable scaffolds and methods of use | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2017-12-05 | — | — | US | disclosed |
| US-20140294783-A1 | IMPLANTABLE SCAFFOLDS AND METHODS OF USE | WEN JIE (US) | 2014-10-02 | — | — | US | disclosed |
| US-20140294783-A1 | IMPLANTABLE SCAFFOLDS AND METHODS OF USE | WEN JIE (US) | 2014-10-02 | — | — | US | disclosed |
| US-20100274012-A1 | Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2010-10-28 | — | — | US | disclosed |
| US-7772393-B2 | Photochemical crosslinkers for polymer coatings and substrate tie-layer | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| US-7772393-B2 | Photochemical crosslinkers for polymer coatings and substrate tie-layer | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| US-20100081750-A1 | Nanotextured Surfaces | INNOVATIVE SURFACE TECHNOLOGIES, INC. | 2010-04-01 | — | — | US | disclosed |
| US-20100081750-A1 | Nanotextured Surfaces | INNOVATIVE SURFACE TECHNOLOGIES, INC. | 2010-04-01 | — | — | US | disclosed |
| EP-2160484-A2 | NANOFIBERS CONTAINING LATENT REACTIVE GROUPS | Innovative Surface Technologies, Inc. (US) | 2010-03-10 | — | — | EP | disclosed |
| WO-2009002869-A2 | NANOFIBERS CONTAINING LATENT REACTIVE GROUPS | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| US-20070003707-A1 | Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer | INNOVATIVE SURFACE TECHNOLOGIES, INC. | 2007-01-04 | — | — | US | disclosed |
| US-20070003707-A1 | Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer | INNOVATIVE SURFACE TECHNOLOGIES, INC. | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070003707-A1 | Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer | TIE1, LIG4, LIG3 | MAPK1 3285/4885ABCB1 2783/4885SMN1; SMN2 4752/4885 |
| US-20100274012-A1 | Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer | TIE1, LIG4, LIG3 | MAPK1 3285/4885ABCB1 2783/4885SMN1; SMN2 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.